Botulinum toxin type A infiltration for pain control after breast augmentation.
Zhibo
Xiao
X
Department of Plastic Surgery; 2nd Affiliated Hospital of Harbin Medical University; Harbin City, Heilongjiang Province China.
Miaobo
Zhang
Z
D000328:Adult; D019274:Botulinum Toxins, Type A / Q000008:administration & dosage / Q000627:therapeutic use*; D019928:Breast Implantation / Q000009:adverse effects* / Q000379:methods; D018427:Breast Implants / Q000009:adverse effects*; D005260:Female; D006801:Humans; D009465:Neuromuscular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D010149:Postoperative Pain / Q000188:drug therapy* / Q000209:etiology; D010369:Pectoralis Muscles / Q000503:physiopathology*; D012107:Research Design; D012189:Retrospective Studies; D020034:Silicone Gels; D013035:Spasm / Q000150:complications* / Q000209:etiology; D016896:Treatment Outcome
D009465:Neuromuscular Agents; D020034:Silicone Gels; D019274:Botulinum Toxins, Type A